Prolonged SARS-CoV-2 infection following rituximab treatment: clinical course and response to therapeutic interventions correlated with quantitative viral cultures and cycle threshold values

Christina S. Thornton, Kevin Huntley, Byron M. Berenger, Michael Bristow, David H. Evans, Kevin Fonseca, Angela Franko, Mark R. Gillrie, Yi-Chan Lin, Marcus Povitz, Mona Shafey, John M. Conly, Alain Tremblay

Open source

DOI: 10.1186/s13756-022-01067-1
Published: 2022-02-05
Container: Antimicrobial Resistance & Infection Control
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13756-022-01067-1,
  title = {Prolonged SARS-CoV-2 infection following rituximab treatment: clinical course and response to therapeutic interventions correlated with quantitative viral cultures and cycle threshold values},
  author = {Christina S. Thornton and Kevin Huntley and Byron M. Berenger and Michael Bristow and David H. Evans and Kevin Fonseca and Angela Franko and Mark R. Gillrie and Yi-Chan Lin and Marcus Povitz and Mona Shafey and John M. Conly and Alain Tremblay},
  year = {2022},
  journal = {Antimicrobial Resistance \&amp; Infection Control},
  doi = {10.1186/s13756-022-01067-1},
  url = {https://doi.org/10.1186/s13756-022-01067-1}
}

RIS

TY  - JOUR
TI  - Prolonged SARS-CoV-2 infection following rituximab treatment: clinical course and response to therapeutic interventions correlated with quantitative viral cultures and cycle threshold values
AU  - Christina S. Thornton
AU  - Kevin Huntley
AU  - Byron M. Berenger
AU  - Michael Bristow
AU  - David H. Evans
AU  - Kevin Fonseca
AU  - Angela Franko
AU  - Mark R. Gillrie
AU  - Yi-Chan Lin
AU  - Marcus Povitz
AU  - Mona Shafey
AU  - John M. Conly
AU  - Alain Tremblay
PY  - 2022
JO  - Antimicrobial Resistance &amp; Infection Control
DO  - 10.1186/s13756-022-01067-1
UR  - https://doi.org/10.1186/s13756-022-01067-1
ER  -

APA

Thornton, C. S., Huntley, K., Berenger, B. M., Bristow, M., Evans, D. H., Fonseca, K., Franko, A., Gillrie, M. R., Lin, Y., Povitz, M., Shafey, M., Conly, J. M., & Tremblay, A. (2022). Prolonged SARS-CoV-2 infection following rituximab treatment: clinical course and response to therapeutic interventions correlated with quantitative viral cultures and cycle threshold values. Antimicrobial Resistance & Infection Control. https://doi.org/10.1186/s13756-022-01067-1

Source records

crossref · retrieved 2026-11-08T15:59:54.975Z